KRAS and pancreatic neoplasm: Human pancreatic cancer cell lines, BxPC-3 and Panc-1, harboring wild and mutant K-ras genotypes, respectively, were treated with garcinol and gemcitabine individually and in combination at different doses and times of incubation, to monitor growth inhibition and degree of apoptotic cell death.